Update on the safety and efficacy of teriparatide in the treatment of osteoporosis

Following the completion of the Fracture Prevention Trial, teriparatide was approved by the United States Food and Drug Administration and the European Medicine Agency as the first therapeutic anabolic agent for the treatment of postmenopausal women with severe osteoporosis. It subsequently received...

Descripción completa

Detalles Bibliográficos
Autores principales: Minisola, Salvatore, Cipriani, Cristiana, Grotta, Giada Della, Colangelo, Luciano, Occhiuto, Marco, Biondi, Piergianni, Sonato, Chiara, Vigna, Evelina, Cilli, Mirella, Pepe, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778993/
https://www.ncbi.nlm.nih.gov/pubmed/31632472
http://dx.doi.org/10.1177/1759720X19877994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778993/
https://www.ncbi.nlm.nih.gov/pubmed/31632472
http://dx.doi.org/10.1177/1759720X19877994

Ejemplares similares